Watch for New Rx PO Semaglutide During Transitions of Care

February 2026

You’ll see patients admitted on Rx semaglutide tablets (Wegovy), the first ORAL GLP-1 agonist FDA-approved for obesity and overweight.

New oral semaglutide is the same med as injectable Wegovy for weight loss...or injectable Ozempic or oral Rybelsus for type 2 diabetes.

But it’s taken DAILY...versus weekly like the injection.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote